Deep Track Capital, LP
Q1 2025 13F Holdings
- Locationgreenwich, CT
- Num holdings
69
- Value ($000)
$3,088,174
- Date Filed05/15/2025
- Form type13F-HR
- CIK0001856083
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ITCI INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | $263.84M | 9 % | 2,000,000 | ||
GH GUARDANT HEALTH INC | COM | 40131M109 | $231.90M | 8 % | 5,443,721 | ||
DVAX DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | $230.76M | 8 % | 17,791,486 | ||
IMVT IMMUNOVANT INC | COM | 45258J102 | $162.35M | 5 % | 9,500,000 | ||
PTGX PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | $145.08M | 5 % | 3,000,000 | ||
ISI IONIS PHARMACEUTICALS INC | COM | 462222100 | $137.70M | 5 % | 4,564,207 | ||
AKRO AKERO THERAPEUTICS INC | COM | 00973Y108 | $129.95M | 4 % | 3,210,270 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $123.54M | 4 % | 3,073,853 | ||
APLS APELLIS PHARMACEUTICALS INC | COM | 03753U106 | $109.35M | 4 % | 5,000,000 | ||
OCUL OCULAR THERAPEUTIX INC | COM | 67576A100 | $104.78M | 3 % | 14,294,420 |
Rows Per Page
10
- 10
- 50
- 100